122 related articles for article (PubMed ID: 7538095)
21. Transgenic expression of human complement regulatory proteins in mice results in diminished complement deposition during organ xenoperfusion.
McCurry KR; Kooyman DL; Diamond LE; Byrne GW; Logan JS; Platt JL
Transplantation; 1995 Apr; 59(8):1177-82. PubMed ID: 7537395
[TBL] [Abstract][Full Text] [Related]
22. [Recent advances in xenotransplantation].
Jeffrey L; Platt MD
Presse Med; 1992 Dec; 21(41):1932-8. PubMed ID: 1294943
[TBL] [Abstract][Full Text] [Related]
23. Complement regulatory proteins in glomerular diseases.
Nangaku M
Kidney Int; 1998 Nov; 54(5):1419-28. PubMed ID: 9844117
[TBL] [Abstract][Full Text] [Related]
24. Evidence that double transfection to xenoendothelial cells using GPI-anchoring complement regulatory factor (decay-accelerating factor and homologous restriction factor 20) gene is useful for the inhibition of human complement-mediated cytolysis.
Hayashi S; Isobe K; Emi N; Okada H; Yasutomi M; Negita M; Koike C; Uchida K; Yokoyama I; Takagi H
Transplant Proc; 1995 Feb; 27(1):330. PubMed ID: 7533402
[No Abstract] [Full Text] [Related]
25. Neutrophil and monocyte cell surface p150,95 has iC3b-receptor (CR4) activity resembling CR3.
Myones BL; Dalzell JG; Hogg N; Ross GD
J Clin Invest; 1988 Aug; 82(2):640-51. PubMed ID: 2969921
[TBL] [Abstract][Full Text] [Related]
26. Characterization of complement-mediated liver damage and protection in control and transgenic mice for human complement blockers MCP and DAF.
Mulder LC; Mora M; Lazzeri M; Boschi M; Ciccopiedi E; Marinucci G; Melli CM; Bruzzone P; Alfani D; Cortesini R; Rossini M
Transplant Proc; 1996 Feb; 28(1):127-9. PubMed ID: 8644143
[No Abstract] [Full Text] [Related]
27. Kidneys derived from mice transgenic for human complement blockers are protected in an in vivo model of hyperacute rejection.
Lazzeri M; Mora M; Mulder LC; Marsicano G; Marinucci G; Boschi M; Bruzzone P; Alfani D; Cortesini R; Rossini M
J Urol; 1998 Apr; 159(4):1364-9. PubMed ID: 9507885
[TBL] [Abstract][Full Text] [Related]
28. Adenovirus-mediated gene transfer of triple human complement regulating proteins (DAF, MCP and CD59) in the xenogeneic porcine-to-human transplantation model. Part I: in vitro assays using porcine aortic endothelial cells.
Nagahama M; Shiraishi M; Oshiro T; Taira K; Sugawa H; Nozato E; Nomura H; Nagamine M; Muto Y
Transpl Int; 2002 May; 15(5):205-11. PubMed ID: 12012040
[TBL] [Abstract][Full Text] [Related]
29. Susceptibility of human trophoblast to killing by human complement and the role of the complement regulatory proteins.
Tedesco F; Narchi G; Radillo O; Meri S; Ferrone S; Betterle C
J Immunol; 1993 Aug; 151(3):1562-70. PubMed ID: 7687635
[TBL] [Abstract][Full Text] [Related]
30. Future directions in transplantation: xenotransplantation.
Somerville CA; d'Apice AJ
Kidney Int Suppl; 1993 Jul; 42():S112-21. PubMed ID: 8361121
[TBL] [Abstract][Full Text] [Related]
31. The role of CD11b/CD18 mediated neutrophil adhesion in complement deficient xenograft recipients.
Jakobs FM; Davis EA; Qian Z; Liu DY; Baldwin WM; Sanfilippo F
Clin Transplant; 1997 Oct; 11(5 Pt 2):516-21. PubMed ID: 9361953
[TBL] [Abstract][Full Text] [Related]
32. Adenovirus-mediated gene transfer of triple human complement regulating proteins (DAF, MCP and CD59) in the xenogeneic porcine-to-human transplantation model. Part II: xenogeneic perfusion of the porcine liver in vivo.
Shiraishi M; Oshiro T; Nozato E; Nagahama M; Taira K; Nomura H; Sugawa H; Muto Y
Transpl Int; 2002 May; 15(5):212-9. PubMed ID: 12012041
[TBL] [Abstract][Full Text] [Related]
33. In vitro and in vivo studies to prevent hyperacute rejection.
Miyagawa S; Mikata M; Matsuda H; Ikawa M; Okabe M; Nagasawa S; Matsumoto M; Seya T; Shirakura R
Transplant Proc; 1996 Apr; 28(2):1031-3. PubMed ID: 8623217
[No Abstract] [Full Text] [Related]
34. Role of complement in xenotransplantation.
Saadi S; Platt JL
Clin Exp Pharmacol Physiol; 1999 Dec; 26(12):1016-9. PubMed ID: 10626074
[TBL] [Abstract][Full Text] [Related]
35. Complement regulation.
Meri S; Jarva H
Vox Sang; 1998; 74 Suppl 2():291-302. PubMed ID: 9704459
[TBL] [Abstract][Full Text] [Related]
36. [The complement system: an old story or target of new therapeutic approaches?].
Heller A; Koch T
Anasthesiol Intensivmed Notfallmed Schmerzther; 2000 Apr; 35(4):207-13. PubMed ID: 10830072
[TBL] [Abstract][Full Text] [Related]
37. ''Homologous restriction'' in complement lysis: roles of membrane complement regulators.
Morgan BP; Berg CW; Harris CL
Xenotransplantation; 2005 Jul; 12(4):258-65. PubMed ID: 15943774
[TBL] [Abstract][Full Text] [Related]
38. Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction.
Saifuddin M; Hedayati T; Atkinson JP; Holguin MH; Parker CJ; Spear GT
J Gen Virol; 1997 Aug; 78 ( Pt 8)():1907-11. PubMed ID: 9266986
[TBL] [Abstract][Full Text] [Related]
39. The control of hyperacute rejection by genetic engineering of the donor species.
White DJ; Cozzi E; Langford G; Oglesby T; Wang MW; Wright L; Wallwork J
Eye (Lond); 1995; 9 ( Pt 2)():185-9. PubMed ID: 7556715
[TBL] [Abstract][Full Text] [Related]
40. Characterization of the human antiporcine immune response: a prerequisite to xenotransplantation.
Bothwell AL
Immunol Res; 1999; 19(2-3):233-43. PubMed ID: 10493177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
